Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance.

Drug Des Devel Ther · 2015 · PMC4364592 · PMID 25792808

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significantP =0.08so close (0.05 < p ≤ 0.1)

However, a borderline significant increase ( P =0.08) was detected in the Q1 subgroup, while a significant decrease ( P =0.01) was found in the Q4 subgroup, and a significant negative correlation ( P <0.01) was found between increase in the lymphocytes during 32 days and the baseline level ( Table 3 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.